iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
16 hedge funds and large institutions have $18.3M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
5% less capital invested
Capital invested by funds: $19.3M → $18.3M (-$986K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$229K |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
+$86.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$47.4K |
| 4 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
+$34.6K |
| 5 |
AIP
Ameritas Investment Partners
Lincoln,
Nebraska
|
+$17.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$878K |
| 2 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
-$501K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$208K |
| 4 |
IF
Ironwood Financial
Tucson,
Arizona
|
-$21K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$4.78K |
IEIH Hedge Fund Activity: Q4 2021 in Review
16 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q4 2021, worth a combined $18.3M — down 5.1% from $19.3M a quarter earlier.
Fund positioning in IEIH was balanced in Q4 2021: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 2 trimmed.
The largest buyer was Cetera Advisor Networks, adding an estimated $229K. The largest seller was Tower Research Capital (TRC), cutting an estimated $878K.
- 16 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $18.3M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q4 2021, down 5.1% quarter-over-quarter.
- 3 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q4 2021 and 3 closed out, a net change of 0 holders.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q4 2021 was Cetera Advisor Networks, an estimated $229K added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q4 2021 was Tower Research Capital (TRC), an estimated $878K sold.
Based on aggregated 13F filings for Q4 2021.